We here show that statin se is associated with a dose-dependent reduction of the expression of selected inflammatory mediators by a mechanism involving reduced vascular NFκB activation in human AAA, a vascular pathology that is not primarily lipid driven [8]. Here, NFKB1 is linked to triple-A syndrome.